Inflecting Value in Early Stage Biotech ( in an Increasingly Cost Conscious Environment): Linking Proof of Relevance to Pricing & Reimbursement
Next Wave of Diagnostics, Including Precision IO: Early and Smarter, the Better to Cure
Vaccines: From Paleo to Neo, Cancer Vaccines in the New Age of IO
Investing into Oncology: Who, What and Where?
Paradigm-shifting platforms II, Non-IO: Targeting Better, Targeting the Intractable
Paradigm-shifting platforms I, IO: Taking IO to the next Level